Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 9.22B |
| Enterprise value | 30.35B |
| Trailing P/E | 872.00 |
| Forward P/E | 3.16 |
| PEG ratio (5-yr expected) | 0.63 |
| Price/sales (ttm) | 0.56 |
| Price/book (mrq) | 0.93 |
| Enterprise value/revenue | 1.95 |
| Enterprise value/EBITDA | 18.08 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.18 |
| 52-week change 3 | -17.90% |
| S&P500 52-week change 3 | -11.93% |
| 52-week high 3 | 10.50 |
| 52-week low 3 | 7.23 |
| 50-day moving average 3 | 8.35 |
| 200-day moving average 3 | 8.72 |
Share statistics
| Avg vol (3-month) 3 | 10.01M |
| Avg vol (10-day) 3 | 14.75M |
| Shares outstanding 5 | 1.11B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 1.1B |
| % held by insiders 1 | 1.50% |
| % held by institutions 1 | 46.07% |
| Shares short (14 June 2022) 4 | 19.38M |
| Short ratio (14 June 2022) 4 | 2.21 |
| Short % of float (14 June 2022) 4 | N/A |
| Short % of shares outstanding (14 June 2022) 4 | 1.75% |
| Shares short (prior month 12 May 2022) 4 | 20.47M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Dec 2017 |
| Ex-dividend date 4 | 26 Nov 2017 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 30 June 2004 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | -3.95% |
| Operating margin (ttm) | 19.25% |
Management effectiveness
| Return on assets (ttm) | 3.90% |
| Return on equity (ttm) | -5.46% |
Income statement
| Revenue (ttm) | 15.56B |
| Revenue per share (ttm) | 14.09 |
| Quarterly revenue growth (yoy) | -8.10% |
| Gross profit (ttm) | 7.59B |
| EBITDA | 4.27B |
| Net income avi to common (ttm) | -615M |
| Diluted EPS (ttm) | -0.56 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.18B |
| Total cash per share (mrq) | 1.96 |
| Total debt (mrq) | 23.31B |
| Total debt/equity (mrq) | 227.19 |
| Current ratio (mrq) | 1.07 |
| Book value per share (mrq) | 8.41 |
Cash flow statement
| Operating cash flow (ttm) | 1.15B |
| Levered free cash flow (ttm) | 2.66B |
© 2022 Yahoo. All rights reserved.
